Calamos Advisors’s 1Life Healthcare ONEM Stock Holding History

Calamos Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-112,448	Closed	-$4.08M	–	754
2020 Q2	$4.08M	Buy	+112,448	New	+$3.17M	0.03%	489

Other funds holding ONEM

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Calamos Advisors's ONEM Position: Q3 2020 in Review

Calamos Advisors sold out of 1Life Healthcare (ONEM) in Q3 2020, closing a stake of 112,448 shares — an estimated $4.08M sold.

Calamos Advisors first reported a position in ONEM in Q2 2020 and held it in 1 quarter. The position peaked at $4.08M in Q2 2020. 183 funds tracked by Wall St. Rank hold ONEM as of Q3 2020.

Calamos Advisors reported no remaining 1Life Healthcare position as of Q3 2020 after selling out during the quarter.
Calamos Advisors sold 112,448 1Life Healthcare shares in Q3 2020, an estimated $4.08M.
Calamos Advisors first reported a position in 1Life Healthcare in Q2 2020 and held it in 1 quarter.
Calamos Advisors's 1Life Healthcare position peaked at $4.08M in Q2 2020.
183 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2020.

Based on Calamos Advisors's 13F filing for Q3 2020, filed 26 Oct 2020.